Travere Therapeutics

About

At Travere Therapeutics, we are dedicated to making a difference for people living with rare kidney disease. Our mission is to identify, develop, and deliver life-changing therapies to people living with rare diseases. We are driven by our commitment to the rare disease community, ensuring that we focus on solutions that address unmet medical needs. Our innovative approach has led to the full FDA approval of a non-immunosuppressive treatment for IgA nephropathy, showcasing our dedication to advancing therapies that improve patient outcomes. Our work is deeply rooted in understanding the complexities and challenges faced by those affected by rare diseases. With a diverse team of individuals who are often connected to these conditions personally, we strive to cultivate a culture of compassion and collaboration. This drives us to not only develop treatments but also to provide extensive support and resources to patients and families navigating their journeys. Through advocacy, partnerships, and research, we aim to transform the landscape of rare disease treatment and deliver hope to those who need it most.